Weiss and Girard-Guyonvarc’h et al. demonstrate the ability of free plasma interleukin-18 (IL-18) to distinguish macrophage activation syndrome (MAS) from other inflammatory disorders [27]. This evidence concerns the gene IL18 and macrophage activation syndrome.